Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Ansell.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but cap raises show money flowing into sector
Health & Biotech
Here’s why Morningstar reckons the ASX healthcare sector is on road to recovery
Experts
ScoPo’s Powerplays: Stress eases as ASX health stocks enjoy much needed rally
Experts
Short selling 101 – How to pick a stock to short sell
Experts
ScoPo’s Powerplays: Hold the presses as KKR pulls bid on Ramsay Healthcare
News
ASX Large Caps: Shares fall 1pc again, T. Rowe Price downgrades Aussie stocks to neutral
News
ASX Small Caps Lunch Wrap: Who else is worried that science has gone too far?
Health & Biotech
ASX Health Stocks: Ansell commits to net zero by 2040, but says Scope 3 needs more work
News
Short & Caught: Short sellers still queuing for volatile FLT?
News
Trading Places: Gold stocks in demand as volatility continues and FY22 draws to a close
News
The Ethical Investor: Tackling modern slavery in the supply chain with Misio’s co-founder Jeremy Biggs
Experts
ScoPo’s Powerplays: Who’s pulling for a health sector recovery?
News
ASX Large Caps: Energy plunges as investors take profit, Tech mounts comeback
Experts
ScoPo’s Powerplays: Who’s staying afloat in the inflation storm?
Experts
ScoPo’s Powerplays: Who’s making a gritty comeback?
News
ASX Large Caps: Tech stocks surge but Ansell tumbles 13pc on earnings downgrade
Health & Biotech